IMRN · Immuron Limited ADR
United States · RS rating 30 · As of 2026-10-14
| Price | 1.03 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 14 / 34 / 14 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 18 / 21 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +56.2% |
| Market cap (USD) | $7.2M |